"The European (EEA and non-EEA countries) database of suspected drug reaction reports is EudraVigilance, verified by the European Medicines Agency (EMA), and they are now reporting 43,898 fatalities, and 4,190,493 injuries following injections of five experimental COVID-19 shots:
COVID-19 MRNA VACCINE MODERNA (CX-024414)
COVID-19 MRNA VACCINE PFIZER-BIONTECH
COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)
COVID-19 VACCINE JANSSEN (AD26.COV2.S)
COVID-19 VACCINE NOVAVAX (NVX-COV2373)
From the total of injuries recorded,
almost half of them (1,914,927 )
are serious injuries.
A Health Impact News subscriber in Europe ran the reports for each of the four COVID-19 shots we are including here. It is a lot of work to tabulate each reaction with injuries and fatalities, since there is no place on the EudraVigilance system we have found that tabulates all the results.
Since we have started publishing this, others from Europe have also calculated the numbers and confirmed the totals.*
Here is the summary data through April 23, 2022.
Total reactions for the mRNA vaccine Tozinameran (code BNT162b2, Comirnaty) from BioNTech/ Pfizer:
20,453 deaths and 2,113,249 injuries
to 23/04/2022
64,924 Blood and lymphatic system disorders incl. 294 deaths
74,047 Cardiac disorders incl. 2,977 deaths
650 Congenital, familial and genetic disorders incl. 63 deaths
27,899 Ear and labyrinth disorders incl. 16 deaths
2,612 Endocrine disorders incl. 10 deaths
31,409 Eye disorders incl. 50 deaths
156,355 Gastrointestinal disorders incl. 812 deaths
527,165 General disorders and administration site conditions incl. 5,673 deaths
2,400 Hepatobiliary disorders incl. 111 deaths
22,536 Immune system disorders incl. 121 deaths
114,664 Infections and infestations incl. 2,132 deaths
41,077 Injury, poisoning and procedural complications incl. 415 deaths
51,449 Investigations incl. 569 deaths
13,595 Metabolism and nutrition disorders incl. 350 deaths
243,668 Musculoskeletal and connective tissue disorders incl. 270 deaths
2,298 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 232 deaths
334,590 Nervous system disorders incl. 2,196 deaths
3,088 Pregnancy, puerperium and perinatal conditions incl. 82 deaths
290 Product issues incl. 3 deaths
37,420 Psychiatric disorders incl. 237 deaths
7,747 Renal and urinary disorders incl. 302 deaths
90,869 Reproductive system and breast disorders incl. 6 deaths
88,205 Respiratory, thoracic and mediastinal disorders incl. 2,175 deaths
94,662 Skin and subcutaneous tissue disorders incl. 178 deaths
5,075 Social circumstances incl. 26 deaths
24,374 Surgical and medical procedures incl. 237 deaths
50,181 Vascular disorders incl. 916 deaths
18,577 Blood and lymphatic system disorders incl. 134 deaths
23,607 Cardiac disorders incl. 1,291 deaths
210 Congenital, familial and genetic disorders incl. 13 deaths
8,042 Ear and labyrinth disorders incl. 8 deaths
684 Endocrine disorders incl. 6 deaths
9,206 Eye disorders incl. 35 deaths
54,975 Gastrointestinal disorders incl. 444 deaths
181,852 General disorders and administration site conditions incl. 3,814 deaths
930 Hepatobiliary disorders incl. 65 deaths
6,852 Immune system disorders incl. 23 deaths
29,491 Infections and infestations incl. 1,081 deaths
11,420 Injury, poisoning and procedural complications incl. 226 deaths
15,150 Investigations incl. 403 deaths
5,602 Metabolism and nutrition disorders incl. 279 deaths
85,537 Musculoskeletal and connective tissue disorders incl. 236 deaths
807 Neoplasms benign, malignant and unspecified (incl. cysts and polyps) incl. 89 deaths
113,835 Nervous system disorders incl. 1,121 deaths
1,009 Pregnancy, puerperium and perinatal conditions incl. 12 deaths
119 Product issues incl. 2 deaths
11,307 Psychiatric disorders incl. 189 deaths
3,656 Renal and urinary disorders incl. 230 deaths
18,486 Reproductive system and breast disorders incl. 9 deaths
28,172 Respiratory, thoracic and mediastinal disorders incl. 1,239 deaths
35,317 Skin and subcutaneous tissue disorders incl. 107 deaths
2,585 Social circumstances incl. 45 deaths
5,391 Surgical and medical procedures incl. 214 deaths
14,515 Vascular disorders incl. 442 deaths
Total reactions for the vaccine AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) from Oxford / AstraZeneca: 8,927 deaths and 1,241,710 injuries to 23/04/2022
14,667 Blood and lymphatic system disorders incl. 315 deaths
22,567 Cardiac disorders incl. 940 deaths
267 Congenital familial and genetic disorders incl. 10 deaths
14,389 Ear and labyrinth disorders incl. 7 deaths
757 Endocrine disorders incl. 6 deaths
21,190 Eye disorders incl. 34 deaths
112,656 Gastrointestinal disorders incl. 475 deaths
330,318 General disorders and administration site conditions incl. 2,069 deaths
1,121 Hepatobiliary disorders incl. 80 deaths
6,057 Immune system disorders incl. 43 deaths
52,751 Infections and infestations incl. 745 deaths
14,667 Injury poisoning and procedural complications incl. 220 deaths
29,637 Investigations incl. 226 deaths
13,879 Metabolism and nutrition disorders incl. 142 deaths
178,457 Musculoskeletal and connective tissue disorders incl. 184 deaths
838 Neoplasms benign malignant and unspecified (incl cysts and polyps) incl. 50 deaths
247,557 Nervous system disorders incl. 1,290 deaths
685 Pregnancy puerperium and perinatal conditions incl. 22 deaths
203 Product issues incl. 1 death
22,343 Psychiatric disorders incl. 78 deaths
4,624 Renal and urinary disorders incl. 91 deaths
17,906 Reproductive system and breast disorders incl. 3 deaths
43,959 Respiratory thoracic and mediastinal disorders incl. 1,197 deaths
55,119 Skin and subcutaneous tissue disorders incl. 77 deaths
2,025 Social circumstances incl. 10 deaths
2,779 Surgical and medical procedures incl. 39 deaths
30,292 Vascular disorders incl. 573 deaths
Total reactions for the COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 2,761 deaths and 147,543 injuries to 23/04/2022
1,471 Blood and lymphatic system disorders incl. 62 deaths
3,186 Cardiac disorders incl. 234 deaths
53 Congenital, familial and genetic disorders incl. 1 death
1,597 Ear and labyrinth disorders incl. 3 deaths
126 Endocrine disorders incl. 2 deaths
1,946 Eye disorders incl. 12 deaths
10,524 Gastrointestinal disorders incl. 101 deaths
39,972 General disorders and administration site conditions incl. 789 deaths
176 Hepatobiliary disorders incl. 17 deaths
649 Immune system disorders incl. 10 deaths
11,492 Infections and infestations incl. 236 deaths
1,388 Injury, poisoning and procedural complications incl. 30 deaths
6,893 Investigations incl. 144 deaths
906 Metabolism and nutrition disorders incl. 74 deaths
18,993 Musculoskeletal and connective tissue disorders incl. 61 deaths
115 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 10 deaths
26,080 Nervous system disorders incl. 269 deaths
90 Pregnancy, puerperium and perinatal conditions incl. 1 death
34 Product issues
2,115 Psychiatric disorders incl. 28 deaths
641 Renal and urinary disorders incl. 39 deaths
3,744 Reproductive system and breast disorders incl. 6 deaths
5,211 Respiratory, thoracic and mediastinal disorders incl. 345 deaths
4,443 Skin and subcutaneous tissue disorders incl. 13 deaths
483 Social circumstances incl. 5 deaths
1,081 Surgical and medical procedures incl. 89 deaths
4,134 Vascular disorders incl. 180 deaths
Total reactions for the COVID-19 vaccine NUVAXOVID (NVX-COV2373) from Novavax:
0 deaths and 657 injuries to 23/04/2022
17 Blood and lymphatic system disorders
37 Cardiac disorders
15 Ear and labyrinth disorders
13 Eye disorders
47 Gastrointestinal disorders
150 General disorders and administration site conditions
2 Hepatobiliary disorders
2 Immune system disorders
23 Infections and infestations
8 Injury, poisoning and procedural complications
22 Investigations
3 Metabolism and nutrition disorders
82 Musculoskeletal and connective tissue disorders
1 Neoplasms benign, malignant and unspecified (incl cysts and polyps)
123 Nervous system disorders
1 Product issues
8 Psychiatric disorders
2 Renal and urinary disorders
10 Reproductive system and breast disorders
26 Respiratory, thoracic and mediastinal disorders
47 Skin and subcutaneous tissue disorders
2 Surgical and medical procedures
16 Vascular disorders
*These totals are estimates based on reports submitted to EudraVigilance. Totals may be much higher based on percentage of adverse reactions that are reported. Some of these reports may also be reported to the individual country’s adverse reaction databases, such as the U.S. VAERS database and the UK Yellow Card system. The fatalities are grouped by symptoms, and some fatalities may have resulted from multiple symptoms."
